Navigation Links
Unexpected signaling role for foul-smelling hydrogen sulfide in cell response to protein misfolding
Date:12/13/2011

Cold Spring Harbor, NY -- Something rotten never smelled so sweet.

This is what members of a team of scientists at Cold Spring Harbor Laboratory (CSHL) are telling one another as they discuss a new finding they did not expect to make. They have discovered that hydrogen sulfide (H2S) the flammable, highly toxic gas that we usually associate with the smell of rotten eggs in landfills and sewers plays an important role in the regulation of a signaling pathway implicated in biological malfunctions linked to Alzheimer's and Parkinson's diseases, among others.

"H2S comes under the category of things that people think of as toxic and nasty, but which can actually be harnessed to serve a useful purpose," says CSHL Professor Nicholas K. Tonks, FRS, who led the research team. In fact, H2S, which is produced naturally in small quantities in various tissues, is a gasotransmitter, one of a family of gaseous signaling molecules that includes nitrous oxide (NO) and carbon monoxide (CO). Unlike growth factors, cytokines and hormones that act through receptors in the cell membrane, these gasotransmitters are able to permeate membranes and enter freely the interior of living cells.

Tonks and colleagues were intrigued by reports in the scientific literature suggesting that H2S was produced as part of the cell's response to what is called ER stress. The ER is the cellular organ called the endoplasmic reticulum. It is an extensive network of membranes spread throughout the cytosol, which is involved in protein synthesis and processing.

When the cell is placed under stress, specifically when newly formed proteins are being manufactured in the ER so rapidly that they do not fold properly, rendering them non-functional, the cell must make a decision either to slow down protein production to match its physiological requirements in the hope that proteins will begin to fold properly or, if that is not sufficient, to commit a form of suicide called apoptosis.

The surprise in the research performed by Tonks' team which is published online today in Science Signaling is that H2S plays a critical role in the exquisitely tuned signaling pathway through which cells make this fateful determination.

Navasona Krishnan, a postdoctoral fellow, performed an experiment to determine whether H2S could covalently modify an enzyme called PTP1B. Discovered by Tonks in 1988, PTP1B is a protein tyrosine phosphatase, or PTP an enzyme that specifically removes phosphate groups from amino acid residues called tyrosines. This function is critical in regulating cellular signaling in normal and disease conditions.

H2S did indeed modify PTP1B, specifically on a cysteine amino acid residue in the enzyme's active site, which inactivated the enzyme. A number of subsequent experiments performed in collaboration with CSHL Professor Darryl Pappin, who directs the proteomics Shared Resource at the Laboratory, identified this modification and revealed that it occurred in vitro and in vivo.

Because PTP1B is itself a signaling pathway regulator, this inactivation was immediately understood to be important and potentially useful. Further experimentation revealed that the H2S-induced modification to PTP1B prevented this phosphatase from inactivating an enzyme called PERK, which is a sensor of the presence of unfolded proteins and a critical regulator of the cell's response to ER stress.

The completed puzzle is as follows: small amounts of hydrogen sulfide are produced when the cell senses ER stress; PTP1B undergoes a unique covalent modification at its active site in response to the H2S that is produced, which in turn prevents the phosphatase from dephosphorylating PERK thereby allowing the latter protein to play its specific regulatory role in response to the stress. Importantly, the process is fully reversible, such that this previously undiscovered pathway can act like a switch, to help fine-tune a response to stress that potentially can lead to cell death.

"We hypothesize that the controlled production of H2S could have a profound impact on how this part of the ER stress pathway the PERK 'arm' is regulated. When proteins are misfolded in response to cellular stress, the inactivation and reactivation of PTP1B appears to be one means by which the cell regulates its protein synthesis machinery and can exert tight control over whether it lives or dies, ," says Tonks.

The linkage of such regulation with human disease is a subject that bears further exploration. ER stress is causally related to the protein-folding-related pathologies seen in such illnesses as Alzheimer's and Parkinson's diseases, Tonks says. "What we are trying to do is understand the structure of PTP1B in the presence and absence of its modification by H2S to define this modification in molecular detail and understand its importance to the control of this major signaling enzyme in normal and disease states."


'/>"/>

Contact: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Related medicine news :

1. MIT researchers discover an unexpected twist in cancer metabolism
2. Unexpectedly small effects of mutations in bacteria bring new perspectives
3. Youth adapt faster than seniors to unexpected events
4. Unexpected find opens up new front in effort to stop HIV
5. Revealing the wiring that allows us to adapt to the unexpected
6. An extra 5 years of life an unexpected benefit of osteoporosis treatment
7. Unexpected new mechanism behind rheumatoid arthritis
8. Mount Sinai researcher finds unexpected temperature sensation for a light detector
9. Metabolic protein plays unexpected role in tumor cell formation and growth
10. Defective signaling pathway sheds light on cystic fibrosis
11. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: